Blood Safety Screening

To reduce the incidence of transfusion transmitted infection

Prevention/Diagnostic
Diagnostic/Prevention
  • PREVENTION
  • DIAGNOSTIC
  • TREATMENT
  • OVERVIEW
  • TECHNOLOGY Characteristics
  • Blood Safety Screening

    GLOBAL ANNUAL DEATHS ASSOCIATED INFECTIONS

    PERCENT (%)
    NUMBER

    Maternal

    20%
    25,000

    Neonatal

    30%
    920,000

    Stillbirth

     

    Condition

    Blood transfusion  is necessary to treat low hematocrit from anemia or blood loss; however, it can transmit infections if the blood is not screened to prevent them. Transfusion transmitted infections (TTI) are a concern, especially in regions where specific viruses, bacteria, and/or parasites may be prevalent. As much as 10% of African HIV transmission may be attributable to blood transfusion. Blood can also cause an immune response and must be  typed to avoid it.

     

    Mechanism of Action

    Blood safety screening prevents the transmission of infectious agents from donor’s blood to those who need it. The first step in reducing infection is a volunteer based blood donor system and associated risk questionnaire. Reducing incentive to donate potentially contaminated blood has reduced the blood screen-out rate in the United States to approximately 1%. Once the blood has been donated, it is screened for infectious agents. 

     

    Depending on resources available, individual samples may be screened for multiple TTIs simultaneously or sequentially. Sequential screening takes time, but may save resources by running the least expensive screens first, throwing out reactive samples, and thereby reducing the number of more expensive tests performed. 

     

    Current use in High-resource settings

    High-resource settings have systems for blood donation and large batch processing. The FDA requires screening for HepB, HepC, HIV, HTLV, Trypanosoma cruzi, West Nile Virus, and syphilis in addition to non-infectious agents. In general, packed red blood cells are preferred over whole blood, as they are associated with decreased patient risk. In addition to testing, the blood is usually processed into components which a particular patient may need more such as packed red blood cells, platelets, or plasma.

     

    Application to Low-resource settings

    Low-resource settings tend to have less systematized blood donation services. 80% of transfusion services in tropical Africa are hospital-based and rely on donors recruited from the patient’s family. When family members are not available, commercial (paid) donors are sometimes used, despite higher risk of TTI. Screening is a major problem, and some estimate that 5-10% of African HIV transmission is through transfusions. Given the personal donation tendency in low-resource settings as well as supply chain and cold chain issues associated with centralized blood banking, point of care diagnostics can be helpful screening tools when blood must be screened in emergency or low-resource situations. Finally, many facilities nearest to births do not have blood transfusion capabilities.

     

    Related Technologies in Development

    Dipstick Blood Test

  • CHARACTERISTICS OF REPRESENTATIVE PRODUCT

    TECHNOLOGY CHARACTERISTICS

    OPERATIONAL PARAMETERS

    POTENTIAL OPPORTUNITIES FOR IMPROVEMENT

    SKILLS

    REQUIRED

    Intended end user
    Training required
    Time required per use
    Nurse, phlebotomist, laboratory technician
    Days
    Hours to do batch processing

    Point of care testing could make the process more efficient for emergency and low volume situations

    ENVIRONMENT/ INFRASTRUCTURE

    Power required
    Waste collection
    Complementary technologies required
    Temperature and storage
    Maintenance
    Depends on methods, but many steps often require power
    Blood waste
    Refrigeration, centrifuge, and microscope are helpful

    Blood transfusion can be done without power, but only if appropriate point of care tests are available and the blood is transferred immediately to the patient without needing refrigeration.

    COST

    Device cost (approximate)
    Cost/course (approximate)
    $2,000-$4,000
    as little as $15

    Point of care tests reduce the capital costs but add to the cost per test

    OTHER

    Portability
    Regulatory
    Efficacy
    Point of care tests are portable, laboratory equipment is not
    If done effectively, screening can reduce the rate of transfusion transmitted infection to about 10 per million.

Sources: The Wall Street Journal. (2010, May 25). New Threats to U.S. Blood Supply. WHO. (2010). Screening Donated Blood for Transfusion-Transmissible Infections -Recommendations.2010: WHO. A Pereira.Economies of scale in blood banking: a study based on data envelopment analysis. Vox Sang. 2006 May;90(4):308-15. E. Kongnyuy et al. Availability of blood for transfusion in maternity units in Malawi. The Internet Journal of Third World Medicine. A. Lara et al. Laboratory costs of a hospital-based blood transfusion service in Malawi. J Clin Pathol 2007;60:1120. S Field et al. Transfusion in sub-Saharan Africa: does a Western model fit? J Clin Pathol. 2007 Oct;60(10):1073-5. Epub 2007 Apr 5.